IP Library Patent Application 19303717
Patent Application
App. No. 19/303,717

KITS AND METHODS FOR BIOLOGICAL SAMPLE PROCESSING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/303,717
Abstract

Methods, apparatuses, and systems are provided for processing a biological sample. Exemplary methods comprise transferring a swab associated with an aliquot of the biological sample into a sample transport media. The methods can provide efficient transfer of a target material such as cells or nucleic acid into the sample transport media for extraction, amplification, and detection of the target material.

Claims (32)

1 . A kit for collection of a biological sample for nucleic acid diagnostic testing, the kit comprising:

(a) a composition comprising at least one protease and an anionic detergent comprising a dodecyl sulfate, wherein the at least one protease is present at about 5.5% w/w to about 6.5% w/w, and wherein the anionic detergent is present at about 2.5% w/w to about 3.5% w/w; and

(b) a swab comprising a stem portion and a tip portion.

2 . The kit of claim 1 , wherein the anionic detergent comprises a sodium salt or a lithium salt.

3 . The kit of claim 2 , wherein the anionic detergent comprises lithium lauryl sulfate.

4 . The kit of claim 1 , wherein the at least one protease is present at about 6% w/w.

5 . The kit of claim 1 , wherein the anionic detergent is present at about 3% w/w.

6 . The kit of claim 1 , wherein the composition is contained in a tube.

7 . The kit of claim 6 , wherein the tube comprises a cap.

8 . The kit of claim 1 , wherein the tip portion of the swab is a flocked tip.

9 . The kit of claim 1 , wherein the stem portion of the swab is a flexible plastic stem.

10 . The kit of claim 1 , wherein the swab is a nasopharyngeal swab or a nasal swab.

11 . The kit of claim 1 , wherein the composition further comprises a buffer.

12 . The kit of claim 11 , wherein the buffer is a phosphate buffer or an alkali salt thereof.

13 . The kit of claim 11 , wherein the buffer comprises HEPES.

14 . The kit of claim 1 , wherein the composition further comprises a divalent cation chelator.

15 . The kit of claim 14 , wherein the divalent cation chelator comprises a magnesium chelator and/or a calcium chelator.

16 . The kit of claim 15 , wherein the divalent cation chelator comprises Trilon M, trisodium citrate, EDTA, or EGTA.

17 . The kit of claim 1 , wherein the composition further comprises a surfactant, wherein the surfactant is present at about 0.5% w/w to about 10% w/w.

18 . The kit of claim 17 , wherein the surfactant is selected from the group consisting of a partially fluorinated alkyl polyether, a c12-c14-secondary ethoxylated alcohol, an anionic low foam surfactant, or a combination thereof.

19 . The kit of claim 1 , wherein the composition further comprises 2% w/v to 3% w/v of a Good's Buffer and 0.05% w/v to 0.3% w/v of a surfactant.

20 . A method for collecting a biological sample for use in a diagnostic test, the method comprising the steps of:

a) contacting the biological sample with a swab comprising a stem portion and a tip portion, wherein at least a first portion of the biological sample is transferred to the tip portion; and

b) contacting the tip portion of the swab with an aqueous composition comprising:

(i) at least one protease, wherein the at least one protease is present at about 5.5% w/w to about 6.5% w/w, and

(ii) an anionic detergent comprising a dodecyl sulfate, wherein the anionic detergent is present at about 2.5% w/w to about 3.5% w/w,

wherein at least a second portion of the biological sample is transferred to the aqueous composition, thereby collecting the biological sample for use in a diagnostic test.

21 . The method of claim 20 , wherein the biological sample is a nasal sample or a nasopharyngeal sample.

22 . The method of claim 20 , wherein the aqueous composition is contained in a tube.

23 . The method of claim 20 , further comprising:

c) performing a nucleic acid diagnostic test on the collected biological sample from step b).

24 . The method of claim 23 , wherein the nucleic acid diagnostic test comprises nucleic acid extraction, amplification, and detection.

Assignments (3)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 072585/0533 Recorded Apr 24, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED; BOLDER SURGICAL, LLC; GYNESONICS, INC.
Reel/Frame 075456/0260 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 15, 2025
From: HOLOGIC, INC.; BOLDER SURGICAL, LLC; GYNESONICS, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A.
Reel/Frame 072585/0533 →